Real-World Use of Selinexor, Daratumumab and Dexamethasone in Chinese Patients With Multiple Myeloma at First Relapse
Clinical trial NCT05559788 · UNKNOWN
Trial details
- NCT number
- NCT05559788
- Sponsor
- Fu chengcheng PhD
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-09-20
- Primary completion
- 2024-06-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.